Page 638«..1020..637638639640..650660..»

Medtronic Receives FDA Approval of an Early Feasibility Study of the Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) system – Cardiology2.0

Posted: Published on September 11th, 2020

Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) system in patients with severe, symptomatic tricuspid regurgitation, a disease in which the diseased, damaged or malfunctioning tricuspid valve allows blood to flow back into the hearts upper right chamber causing eventual heart failure or death. The study begins on the heels of a recent Breakthrough Device Designation issued by the FDA for the Intrepid TTVR System Continue reading

Posted in Interventional Cardiology | Comments Off on Medtronic Receives FDA Approval of an Early Feasibility Study of the Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) system – Cardiology2.0

How the coronavirus causes ‘carnage’ in the heart – The Daily Briefing

Posted: Published on September 11th, 2020

New research shows that the novel coronavirus can essentially dice the muscle fibers of the human heart into pieces, sparking concerns about the potential for heart failure among Covid-19 survivors, Elizabeth Cooney reports for STAT News. Resources to support your CV telehealth strategy For the study, which was published preprint on bioRxiv and has not yet been peer reviewed, researchers added the new coronavirus, SARS-CoV-2, to three types of human heart cellscardiomyocytes, cardiac fibroblasts, and endothelial cellsthat were grown in lab dishes from stem cells. Only the cardiomyocytes, which are muscle cells, showed indication of viral infection that spread to other muscle cells, the researchers said Continue reading

Posted in Interventional Cardiology | Comments Off on How the coronavirus causes ‘carnage’ in the heart – The Daily Briefing

Oncomfort creates cushion for growth with 10M series A fundraising – BioWorld Online

Posted: Published on September 11th, 2020

Oncomfort SA finalized a 10 million (US$11.8 million) series A fundraising round to further develop its Digital Sedation product and pursue international expansion. Debiopharm and Crdit Mutuel Innovation led the round with participation from Wallonia Innovation and Growth and previous investors. Digital Sedation uses virtual reality to deliver clinical hypnotherapy combined with integrative therapeutic techniques to relieve patients' pain and anxiety before, during and after medical procedures without medication Continue reading

Posted in Interventional Cardiology | Comments Off on Oncomfort creates cushion for growth with 10M series A fundraising – BioWorld Online

Interventional Cardiology Market Insights Business Opportunities, Current Trends And Restraints Forecast by 2026 – The Market Chronicles

Posted: Published on September 11th, 2020

The Interventional Cardiology Market Report 2020 supplies a thorough opinion, clarify the segments on the industry scope and also the market enlarged insights and forecast by 2026. It shows market statistics according to industry drivers, restraints and chances, and examines the Interventional Cardiology industry status, the business share, size, prospective trends and growth rate of the market Continue reading

Posted in Interventional Cardiology | Comments Off on Interventional Cardiology Market Insights Business Opportunities, Current Trends And Restraints Forecast by 2026 – The Market Chronicles

More than 3 billion people protected from harmful trans fat in their food – World Health Organization

Posted: Published on September 9th, 2020

Two years into the World Health Organizations (WHO) ambitious effort to eliminate industrially produced trans fats from the global food supply, the Organization reports that 58 countries so far have introduced laws that will protect 3.2 billion people from the harmful substance by the end of 2021. Continue reading

Posted in Coronary Heart Diseases | Comments Off on More than 3 billion people protected from harmful trans fat in their food – World Health Organization

Aortic Dissection: Still the Great Masquerader – Medscape

Posted: Published on September 9th, 2020

Ask any trainee in emergency medicine for a list of rapidly fatal conditions, and it is almost certain that acute aortic dissection (AAD) will be near the top. In acute care medicine, AAD is a condition we think about multiple times per day. Emergency medicine training is focused on such life threats; we are taught to think of the worst conditions first Continue reading

Posted in Coronary Heart Diseases | Comments Off on Aortic Dissection: Still the Great Masquerader – Medscape

Most New Zealanders don’t know how deadly strokes are claiming 2,300 lives a year and rising – The Conversation AU

Posted: Published on September 9th, 2020

Stroke is the third highest cause of death in New Zealand, after cancer and coronary heart disease. But our new research shows very few people are aware of the risk, particularly in Pasifika communities despite being much more likely to have an early stroke Continue reading

Posted in Coronary Heart Diseases | Comments Off on Most New Zealanders don’t know how deadly strokes are claiming 2,300 lives a year and rising – The Conversation AU

Deaths in Scotland rise by a third during coronavirus pandemic – The National

Posted: Published on September 9th, 2020

THE totalnumber of deaths in Scotland soared by a third between April and June, new figures reveal. The National Records of Scotland (NRS) statistics showed 18,201 people died during the period, 4515 more than the five-year average. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Deaths in Scotland rise by a third during coronavirus pandemic – The National

Acute Care Market size forecast to reach $214.3 billion by 2025 – Reported Times

Posted: Published on September 9th, 2020

Medical Condition Segment Analysis Emergency Care held the largest share in the medical condition segment of Acute Care Market in 2019 and is estimated to grow at a CAGR of 7.5% during the forecast period 2020-2025. Frontline providers manage children and adults with medical, surgical and obstetric emergencies, including injuries and infections, heart attacks and strokes, asthma and acute complications of pregnancy. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Acute Care Market size forecast to reach $214.3 billion by 2025 – Reported Times

The Association of Statins for Secondary Prevention with Progression to Diabetes in Patients with Prediabetic State After Coronary Artery Bypass Graft…

Posted: Published on September 9th, 2020

Aim:Despite proven benefits of statins for secondary prevention of coronary artery diseases, their diabetogenic effect is still controversial. We aimed to examine the occurrence of type 2 diabetes mellitus (T2DM) in prediabetic patients after coronary artery bypass grafting (CABG). Methods:The retrospective cohort population comprised of post-CABG patients who were prediabetic at the time of surgery and were taking statins Continue reading

Posted in Coronary Heart Diseases | Comments Off on The Association of Statins for Secondary Prevention with Progression to Diabetes in Patients with Prediabetic State After Coronary Artery Bypass Graft…

Page 638«..1020..637638639640..650660..»